サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1701670

インフルエンザ迅速診断検査（RIDT）の世界市場：産業分析、規模、シェア、成長、動向、予測（2025年～2032年）

Rapid Influenza Diagnostic Tests Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

出版日
ページ情報
英文 242 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
インフルエンザ迅速診断検査（RIDT）の世界市場：産業分析、規模、シェア、成長、動向、予測（2025年～2032年）
出版日: 2025年04月08日
発行: Persistence Market Research
ページ情報: 英文 242 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

主な調査結果

  • インフルエンザ迅速診断検査（RIDT）の市場規模：9億8,200万米ドル（2025年）
  • 予測される市場金額：17億4,950万米ドル（2032年）
  • 世界市場の成長率：8.6%（2025年～2032年のCAGR）

インフルエンザ迅速診断検査（RIDT）市場 - レポート範囲

インフルエンザ迅速診断検査（RIDT）市場には、呼吸器検体中のインフルエンザウイルス抗原を短時間（多くの場合30分以内）で検出するように設計された診断ツールが含まれます。これらの検査は、特に季節的流行時やパンデミック時に、インフルエンザ感染をタイムリーに診断・管理するポイントオブケア環境において極めて重要です。イムノアッセイの技術的進歩、疾病の早期発見に対する意識の高まり、世界的な健康上の脅威の増大が、市場の勢いに大きく寄与しています。

市場成長の促進要因

世界のRIDT市場の成長は、季節性インフルエンザやパンデミックインフルエンザの発生件数の増加によるところが大きく、迅速で正確なポイントオブケア診断への需要が高まっています。政府や医療機関による公衆衛生活動や監視プログラムの強化により、感染を抑制するための早期発見への注目が高まっています。さらに、より高感度で特異的なRIDTの開発など、デジタル診断や分子診断における技術革新は、臨床応用の幅と信頼性を広げています。在宅医療環境や遠隔地の医療環境におけるこれらの検査の採用の拡大が、市場への浸透をさらに加速させています。さらに、重篤なインフルエンザ合併症のリスクが高い高齢者の世界的な増加も、迅速で簡便な診断に対する需要に寄与しています。

市場抑制要因

旺盛な需要にもかかわらず、RIDT市場は大きな制約に直面しています。主な制限は、従来の迅速検査の感度がRT-PCRのような検査室ベースの手法に比べて相対的に低いことであり、これは偽陰性につながり、その後の臨床的意思決定に課題をもたらします。この制限は、特にクリティカルケアの状況において、検査結果に対する臨床医の信頼を妨げる可能性があります。さらに、インフルエンザウイルスの変異による検査性能のばらつきは、診断精度を一定に保つための課題となっています。規制上のハードルや製品のリコールも、特に革新的な診断の商業化を目指す新規参入企業にとっては、市場の進歩を妨げる要因となります。さらに、資源が限られた環境では、コストの制限や早期検査の利点に関する認識不足がRIDTの普及を抑制する可能性があります。

市場機会

こうした課題がある中、RIDT市場には複数の有利な成長機会があります。分子診断、特にNAATベースの迅速検査の統合が進んでおり、これは感度が高く所要時間が短縮されるため、臨床/非臨床環境で好ましい選択肢として位置づけられています。遠隔医療と分散型医療の拡大により、使いやすいデジタル検査キットに支えられた在宅インフルエンザ検査の新たなチャネルが開かれました。特にアジア太平洋とラテンアメリカの新興経済圏は、医療インフラへの投資の増加と意識の高まりにより、未開発の市場可能性を提供しています。さらに、診断企業と公衆衛生機関との戦略的提携は、イノベーションを促進し、次世代RIDTの展開を加速する可能性があります。パンデミックへの備えと感染症監視への投資も、市場拡大に向けた肥沃な土壌を形成しています。

当レポートでは、世界のインフルエンザ迅速診断検査（RIDT）市場について調査し、成長促進要因、動向、機会、課題などの市場力学の詳細な分析を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の概要

  • 市場の範囲と定義
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
    • 主要動向
  • マクロ経済要因
    • 世界の部門の見通し
    • 世界のGDP成長の見通し
  • COVID-19の影響の分析
  • 予測要因 - 関連性と影響

第3章 付加価値考察

  • 製品採用分析
  • 疾病の疫学
  • 技術の進歩
  • 規制情勢
  • バリューチェーン分析
  • 主な取引と合併
  • PESTLE分析
  • ポーターのファイブフォース分析

第4章 世界のインフルエンザ迅速診断検査（RIDT）市場の見通し

  • 主なハイライト
    • 市場規模と前年比成長
    • 絶対的収益機会
  • 市場規模の分析と予測
    • 市場規模の実績の分析（2019年～2024年）
    • 現在の市場規模の分析と予測（2025年～2032年）
  • 世界のインフルエンザ迅速診断検査（RIDT）市場の見通し：製品タイプ別
    • イントロダクション/主な調査結果
    • 市場規模の実績と分析：製品タイプ別（2019年～2024年）
    • 現在の市場規模の分析と予測：製品タイプ別（2025年～2032年）
    • 市場の魅力分析：製品タイプ別
  • 世界のインフルエンザ迅速診断検査（RIDT）市場の見通し：検査タイプ
    • イントロダクション/主な調査結果
    • 市場規模の実績の分析：検査タイプ別（2019年～2024年）
    • 現在の市場規模の分析と予測：検査タイプ別（2025年～2032年）
    • 市場の魅力分析：検査タイプ
  • 世界のインフルエンザ迅速診断検査（RIDT）市場の見通し：アッセイタイプ
    • イントロダクション/主な調査結果
    • 市場規模の実績の分析：アッセイタイプ別（2019年～2024年）
    • 現在の市場規模の分析と予測：アッセイタイプ別（2025年～2032年）
    • 市場の魅力分析：アッセイタイプ
  • 世界のインフルエンザ迅速診断検査（RIDT）市場の見通し：サンプルタイプ
    • イントロダクション/主な調査結果
    • 市場規模の実績の分析：サンプルタイプ別（2019年～2024年）
    • 現在の市場規模の分析と予測：サンプルタイプ別（2025年～2032年）
    • 市場の魅力分析：サンプルタイプ
  • 世界のインフルエンザ迅速診断検査（RIDT）市場の見通し：エンドユーザー
    • イントロダクション/主な調査結果
    • 市場規模の実績の分析：エンドユーザー別（2019年～2024年）
    • 現在の市場規模の分析と予測：エンドユーザー別（2025年～2032年）
    • 市場の魅力分析：エンドユーザー

第5章 世界のインフルエンザ迅速診断検査（RIDT）市場の見通し：地域

  • 主なハイライト
  • 市場規模の実績の分析：地域別（2019年～2024年）
  • 現在の市場規模の分析と予測：地域別（2025年～2032年）
    • 北米
    • 欧州
    • 東アジア
    • 南アジア・オセアニア
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力分析：地域

第6章 北米のインフルエンザ迅速診断検査（RIDT）市場の見通し

第7章 欧州のインフルエンザ迅速診断検査（RIDT）市場の見通し

第8章 東アジアのインフルエンザ迅速診断検査（RIDT）市場の見通し

第9章 南アジア・オセアニアのインフルエンザ迅速診断検査（RIDT）市場の見通し

第10章 ラテンアメリカのインフルエンザ迅速診断検査（RIDT）市場の見通し

第11章 中東・アフリカのインフルエンザ迅速診断検査（RIDT）市場の見通し

第12章 競合情勢

  • 市場シェア分析（2025年）
  • 市場構造
    • 競合強度マップ：市場別
    • 競合ダッシュボード
  • 企業プロファイル（詳細 - 概要、財務、戦略、近年の発展）
    • QuidelOrtho Corporation
    • BD
    • Thermo Fisher Scientific Inc.
    • Abbott
    • F. Hoffmann-La Roche Ltd
    • DiaSorin SpA
    • Meridian Life Science, Inc.
    • SEKISUI Diagnostics
    • Virax Biolabs
    • ACCESS BIO
    • Princeton BioMeditech Corporation
    • LifeSign LLC.
    • McKesson Medical-Surgical Inc.
    • Pfizer Inc.
    • EBOS Healthcare
    • KANEKA CORPORATION
    • Siemens Healthcare Private Limited
    • Healgen
    • iHealth Labs Inc.
    • SG Diagnostics
    • Flowflex UK
    • その他

第13章 付録

目次
Product Code: PMRREP31040

Persistence Market Research has recently released a comprehensive report on the global Rapid Influenza Diagnostic Tests (RIDTs) Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Rapid Influenza Diagnostic Tests Market Size (2025E): US$ 982.0 Mn
  • Projected Market Value (2032F): US$ 1,749.5 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 8.6%

Rapid Influenza Diagnostic Tests Market - Report Scope:

The Rapid Influenza Diagnostic Tests (RIDTs) market encompasses diagnostic tools designed to detect influenza viral antigens in respiratory specimens within a short time frame, often under 30 minutes. These tests are crucial in point-of-care settings for timely diagnosis and management of influenza infections, especially during seasonal outbreaks or pandemics. Technological advancements in immunoassays, growing awareness of early disease detection, and increasing global health threats have significantly contributed to the market's momentum.

Market Growth Drivers:

The growth of the global RIDTs market is largely driven by rising incidences of seasonal and pandemic influenza, which has increased the demand for rapid and accurate point-of-care diagnostics. Enhanced public health initiatives and surveillance programs by governments and healthcare agencies have amplified the focus on early detection to curb transmission. In addition, technological innovations in digital and molecular diagnostics, including the development of more sensitive and specific RIDTs, have broadened clinical applications and reliability. The growing adoption of these tests in home care settings and remote healthcare environments further accelerates their market penetration. Moreover, the global increase in geriatric populations, who are at higher risk of severe influenza complications, adds to the demand for faster and convenient diagnostics.

Market Restraints:

Despite strong demand, the RIDTs market faces notable constraints. A key limitation lies in the relatively lower sensitivity of some conventional rapid tests compared to laboratory-based methods such as RT-PCR, leading to false negatives and subsequent challenges in clinical decision-making. This limitation can hinder clinician confidence in test results, especially in critical care scenarios. Additionally, variability in test performance due to mutations in influenza viruses poses challenges to maintaining consistent diagnostic accuracy. Regulatory hurdles and product recalls can also impede market progress, particularly for new entrants aiming to commercialize innovative diagnostics. Moreover, in resource-limited settings, cost constraints and lack of awareness about the benefits of early testing can restrict the widespread adoption of RIDTs.

Market Opportunities:

Amidst these challenges, the RIDTs market presents several lucrative growth opportunities. The increasing integration of molecular diagnostics, particularly NAAT-based rapid tests, offers high sensitivity with reduced turnaround times, positioning them as a preferred alternative in clinical and non-clinical settings. Expansion of telemedicine and decentralized healthcare has opened new channels for home-based influenza testing, supported by user-friendly digital test kits. Emerging economies, particularly in Asia-Pacific and Latin America, offer untapped market potential due to rising healthcare infrastructure investments and growing awareness. Furthermore, strategic collaborations between diagnostic companies and public health organizations can foster innovation and accelerate deployment of next-generation RIDTs. The ongoing focus on pandemic preparedness and investments in infectious disease surveillance also create fertile ground for market expansion.

Key Questions Answered in the Report:

  • What are the primary factors driving the global RIDTs market's growth?
  • Which regions and segments are witnessing the highest adoption of RIDTs?
  • How are technological advancements reshaping diagnostic accuracy and speed?
  • Who are the leading players in the RIDTs market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and market forecasts for the next decade?

Competitive Intelligence and Business Strategy:

Leading players in the global RIDTs market, such as QuidelOrtho Corporation, BD, Abbott, and Thermo Fisher Scientific Inc., are heavily investing in the development of advanced diagnostic platforms with improved sensitivity and faster result delivery. These companies are also focusing on expanding their geographic footprint through mergers, partnerships, and distribution agreements. Innovations such as multiplex assays capable of detecting both influenza A and B simultaneously, and digital diagnostics with smartphone connectivity, are key strategic areas. Other players, including DiaSorin S.p.A., Meridian Life Science, and Virax Biolabs, are enhancing their assay technologies and collaborating with health authorities to bolster public health preparedness. Strengthening presence in home care and remote diagnostics through user-friendly formats continues to be a central strategy for competitive differentiation.

Companies Covered in This Report:

  • QuidelOrtho Corporation
  • BD
  • Thermo Fisher Scientific Inc.
  • Abbott
  • F. Hoffmann-La Roche Ltd
  • DiaSorin S.p.A.
  • Meridian Life Science, Inc.
  • SEKISUI Diagnostics
  • Virax Biolabs
  • ACCESS BIO
  • Princeton BioMeditech Corporation
  • LifeSign LLC.
  • McKesson Medical-Surgical Inc.
  • Pfizer Inc.

Rapid Influenza Diagnostic Tests Market Segmentation:

By Product Type:

  • Conventional
  • Digital

By Test Type:

  • Influenza A Test
  • Influenza B Test
  • Influenza A+B Test

By Assay Type:

  • Immunochromatographic Assays
  • Immunofluorescence Assays
  • Nucleic Acid Amplification Test (NAAT)

By Sample Type:

  • Throat Swab
  • Nasal Swab
  • Nasal Aspirate
  • Nasopharyngeal Swab
  • Nasopharyngeal Aspirate
  • Nasopharyngeal Wash

By End User:

  • Hospitals & Clinics
  • Diagnostic Centers & Laboratories
  • Nursing Homes
  • Home Care Settings
  • Others

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Rapid Influenza Diagnostic Tests Market Snapshot, 2025-2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Disease Epidemiology
  • 3.3. Technological Advancement
  • 3.4. Regulatory Landscape
  • 3.5. Value Chain Analysis
  • 3.6. Key Deals and Mergers
  • 3.7. PESTLE Analysis
  • 3.8. Porter's Five Force Analysis

4. Global Rapid Influenza Diagnostic Tests Market Outlook:

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Mn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
    • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 4.3. Global Rapid Influenza Diagnostic Tests Market Outlook: Product Type
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Mn) and Analysis, By Product Type, 2019-2024
    • 4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
      • 4.3.3.1. Conventional
      • 4.3.3.2. Digital
    • 4.3.4. Market Attractiveness Analysis: Product Type
  • 4.4. Global Rapid Influenza Diagnostic Tests Market Outlook: Test Type
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Mn) Analysis, By Test Type, 2019-2024
    • 4.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
      • 4.4.3.1. Influenza A Test
      • 4.4.3.2. Influenza B Test
      • 4.4.3.3. Influenza A+B Test
    • 4.4.4. Market Attractiveness Analysis: Test Type
  • 4.5. Global Rapid Influenza Diagnostic Tests Market Outlook: Assay Type
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Mn) Analysis, By Assay Type, 2019-2024
    • 4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Assay Type, 2025-2032
      • 4.5.3.1. Immunochromatographic Assays
      • 4.5.3.2. Immunofluorescence Assays
      • 4.5.3.3. Nucleic Acid Amplification Test (NAAT)
    • 4.5.4. Market Attractiveness Analysis: Assay Type
  • 4.6. Global Rapid Influenza Diagnostic Tests Market Outlook: Sample Type
    • 4.6.1. Introduction / Key Findings
    • 4.6.2. Historical Market Size (US$ Mn) Analysis, By Sample Type, 2019-2024
    • 4.6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Sample Type, 2025-2032
      • 4.6.3.1. Throat Swab
      • 4.6.3.2. Nasal Swab
      • 4.6.3.3. Nasal Aspirate
      • 4.6.3.4. Nasopharyngeal Swab
      • 4.6.3.5. Nasopharyngeal Aspirate
      • 4.6.3.6. Nasopharyngeal Wash
    • 4.6.4. Market Attractiveness Analysis: Sample Type
  • 4.7. Global Rapid Influenza Diagnostic Tests Market Outlook: End User
    • 4.7.1. Introduction / Key Findings
    • 4.7.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
    • 4.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
      • 4.7.3.1. Hospitals & Clinics
      • 4.7.3.2. Diagnostic Centers & Laboratories
      • 4.7.3.3. Nursing Homes
      • 4.7.3.4. Home Care Settings
      • 4.7.3.5. Others
    • 4.7.4. Market Attractiveness Analysis: End User

5. Global Rapid Influenza Diagnostic Tests Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
  • 5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Rapid Influenza Diagnostic Tests Market Outlook:

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Product Type
    • 6.2.3. By Test Type
    • 6.2.4. By Assay Type
    • 6.2.5. By Sample Type
    • 6.2.6. By End User
  • 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 6.4.1. Conventional
    • 6.4.2. Digital
  • 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 6.5.1. Influenza A Test
    • 6.5.2. Influenza B Test
    • 6.5.3. Influenza A+B Test
  • 6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Assay Type, 2025-2032
    • 6.6.1. Immunochromatographic Assays
    • 6.6.2. Immunofluorescence Assays
    • 6.6.3. Nucleic Acid Amplification Test (NAAT)
  • 6.7. Current Market Size (US$ Mn) Analysis and Forecast, By Sample Type, 2025-2032
    • 6.7.1. Throat Swab
    • 6.7.2. Nasal Swab
    • 6.7.3. Nasal Aspirate
    • 6.7.4. Nasopharyngeal Swab
    • 6.7.5. Nasopharyngeal Aspirate
    • 6.7.6. Nasopharyngeal Wash
  • 6.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 6.8.1. Hospitals & Clinics
    • 6.8.2. Diagnostic Centers & Laboratories
    • 6.8.3. Nursing Homes
    • 6.8.4. Home Care Settings
    • 6.8.5. Others
  • 6.9. Market Attractiveness Analysis

7. Europe Rapid Influenza Diagnostic Tests Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product Type
    • 7.2.3. By Test Type
    • 7.2.4. By Assay Type
    • 7.2.5. By Sample Type
  • 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 7.4.1. Conventional
    • 7.4.2. Digital
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 7.5.1. Influenza A Test
    • 7.5.2. Influenza B Test
    • 7.5.3. Influenza A+B Test
  • 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Assay Type, 2025-2032
    • 7.6.1. Immunochromatographic Assays
    • 7.6.2. Immunofluorescence Assays
    • 7.6.3. Nucleic Acid Amplification Test (NAAT)
  • 7.7. Current Market Size (US$ Mn) Analysis and Forecast, By Sample Type, 2025-2032
    • 7.7.1. Throat Swab
    • 7.7.2. Nasal Swab
    • 7.7.3. Nasal Aspirate
    • 7.7.4. Nasopharyngeal Swab
    • 7.7.5. Nasopharyngeal Aspirate
    • 7.7.6. Nasopharyngeal Wash
  • 7.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 7.8.1. Hospitals & Clinics
    • 7.8.2. Diagnostic Centers & Laboratories
    • 7.8.3. Nursing Homes
    • 7.8.4. Home Care Settings
    • 7.8.5. Others
  • 7.9. Market Attractiveness Analysis

8. East Asia Rapid Influenza Diagnostic Tests Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product Type
    • 8.2.3. By Test Type
    • 8.2.4. By Assay Type
    • 8.2.5. By Sample Type
  • 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 8.4.1. Conventional
    • 8.4.2. Digital
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 8.5.1. Influenza A Test
    • 8.5.2. Influenza B Test
    • 8.5.3. Influenza A+B Test
  • 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Assay Type, 2025-2032
    • 8.6.1. Immunochromatographic Assays
    • 8.6.2. Immunofluorescence Assays
    • 8.6.3. Nucleic Acid Amplification Test (NAAT)
  • 8.7. Current Market Size (US$ Mn) Analysis and Forecast, By Sample Type, 2025-2032
    • 8.7.1. Throat Swab
    • 8.7.2. Nasal Swab
    • 8.7.3. Nasal Aspirate
    • 8.7.4. Nasopharyngeal Swab
    • 8.7.5. Nasopharyngeal Aspirate
    • 8.7.6. Nasopharyngeal Wash
  • 8.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 8.8.1. Hospitals & Clinics
    • 8.8.2. Diagnostic Centers & Laboratories
    • 8.8.3. Nursing Homes
    • 8.8.4. Home Care Settings
    • 8.8.5. Others
  • 8.9. Market Attractiveness Analysis

9. South Asia & Oceania Rapid Influenza Diagnostic Tests Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product Type
    • 9.2.3. By Test Type
    • 9.2.4. By Assay Type
    • 9.2.5. By Sample Type
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 9.4.1. Conventional
    • 9.4.2. Digital
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 9.5.1. Influenza A Test
    • 9.5.2. Influenza B Test
    • 9.5.3. Influenza A+B Test
  • 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Assay Type, 2025-2032
    • 9.6.1. Immunochromatographic Assays
    • 9.6.2. Immunofluorescence Assays
    • 9.6.3. Nucleic Acid Amplification Test (NAAT)
  • 9.7. Current Market Size (US$ Mn) Analysis and Forecast, By Sample Type, 2025-2032
    • 9.7.1. Throat Swab
    • 9.7.2. Nasal Swab
    • 9.7.3. Nasal Aspirate
    • 9.7.4. Nasopharyngeal Swab
    • 9.7.5. Nasopharyngeal Aspirate
    • 9.7.6. Nasopharyngeal Wash
  • 9.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 9.8.1. Hospitals & Clinics
    • 9.8.2. Diagnostic Centers & Laboratories
    • 9.8.3. Nursing Homes
    • 9.8.4. Home Care Settings
    • 9.8.5. Others
  • 9.9. Market Attractiveness Analysis

10. Latin America Rapid Influenza Diagnostic Tests Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product Type
    • 10.2.3. By Test Type
    • 10.2.4. By Assay Type
    • 10.2.5. By Sample Type
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 10.4.1. Conventional
    • 10.4.2. Digital
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 10.5.1. Influenza A Test
    • 10.5.2. Influenza B Test
    • 10.5.3. Influenza A+B Test
  • 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Assay Type, 2025-2032
    • 10.6.1. Immunochromatographic Assays
    • 10.6.2. Immunofluorescence Assays
    • 10.6.3. Nucleic Acid Amplification Test (NAAT)
  • 10.7. Current Market Size (US$ Mn) Analysis and Forecast, By Sample Type, 2025-2032
    • 10.7.1. Throat Swab
    • 10.7.2. Nasal Swab
    • 10.7.3. Nasal Aspirate
    • 10.7.4. Nasopharyngeal Swab
    • 10.7.5. Nasopharyngeal Aspirate
    • 10.7.6. Nasopharyngeal Wash
  • 10.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 10.8.1. Hospitals & Clinics
    • 10.8.2. Diagnostic Centers & Laboratories
    • 10.8.3. Nursing Homes
    • 10.8.4. Home Care Settings
    • 10.8.5. Others
  • 10.9. Market Attractiveness Analysis

11. Middle East & Africa Rapid Influenza Diagnostic Tests Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product Type
    • 11.2.3. By Test Type
    • 11.2.4. By Assay Type
    • 11.2.5. By Sample Type
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 11.4.1. Conventional
    • 11.4.2. Digital
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 11.5.1. Influenza A Test
    • 11.5.2. Influenza B Test
    • 11.5.3. Influenza A+B Test
  • 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Assay Type, 2025-2032
    • 11.6.1. Immunochromatographic Assays
    • 11.6.2. Immunofluorescence Assays
    • 11.6.3. Nucleic Acid Amplification Test (NAAT)
  • 11.7. Current Market Size (US$ Mn) Analysis and Forecast, By Sample Type, 2025-2032
    • 11.7.1. Throat Swab
    • 11.7.2. Nasal Swab
    • 11.7.3. Nasal Aspirate
    • 11.7.4. Nasopharyngeal Swab
    • 11.7.5. Nasopharyngeal Aspirate
    • 11.7.6. Nasopharyngeal Wash
  • 11.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 11.8.1. Hospitals & Clinics
    • 11.8.2. Diagnostic Centers & Laboratories
    • 11.8.3. Nursing Homes
    • 11.8.4. Home Care Settings
    • 11.8.5. Others
  • 11.9. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping by Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. QuidelOrtho Corporation
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Product Type
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. BD
    • 12.3.3. Thermo Fisher Scientific Inc.
    • 12.3.4. Abbott
    • 12.3.5. F. Hoffmann-La Roche Ltd
    • 12.3.6. DiaSorin S.p.A.
    • 12.3.7. Meridian Life Science, Inc.
    • 12.3.8. SEKISUI Diagnostics
    • 12.3.9. Virax Biolabs
    • 12.3.10. ACCESS BIO
    • 12.3.11. Princeton BioMeditech Corporation
    • 12.3.12. LifeSign LLC.
    • 12.3.13. McKesson Medical-Surgical Inc.
    • 12.3.14. Pfizer Inc.
    • 12.3.15. EBOS Healthcare
    • 12.3.16. KANEKA CORPORATION
    • 12.3.17. Siemens Healthcare Private Limited
    • 12.3.18. Healgen
    • 12.3.19. iHealth Labs Inc.
    • 12.3.20. SG Diagnostics
    • 12.3.21. Flowflex UK
    • 12.3.22. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations